中山静海县痔疮医院(中山有什么可以治痔疮) (今日更新中)

BEIJING, Jan. 25 (Xinhua) -- China's railway authorities said Wednesday that it would put 315 more trains into service on Wednesday to cope with Lunar New Year travel demand, compared with 159 on Tuesday.About 3.7 million passengers hit the rails on Tuesday, up from 2.29 million on Monday, the Ministry of Railways said in a statement on its website.The ministry expected a post-festival travel peak on Friday.The country's trains carried a total of 83.46 million passengers from Jan. 8 to 22, up 7.9 percent from a year earlier, the ministry said in a statement issued on Tuesday.The 40-day Spring Festival travel season kicked off on Jan. 8 this year, with hundreds of millions of people, mainly migrant workers and college students, heading home for the most important festival in China.A total of 3.16 billion passenger trips are expected during the year's travel rush, up 9.1 percent from a year earlier. Of those journeys, 235 million are likely to be made by train, up 6.1 percent year-on-year.The Spring Festival, or Chinese Lunar New Year, falls on Jan. 23 this year. 

WASHINGTON, Jan. 1 (Xinhua) -- Twin U.S. spacecraft to study the moon from crust to core put themselves into the lunar orbit on New Year's Eve and New Year's Day, the country's space agency said.The second Gravity Recovery And Interior Laboratory, or GRAIL-B, reached its lunar orbit at 5:43 p.m. EST (2243 GMT) on Sunday, according to the National Aeronautics and Space Administration (NASA).The GRAIL-A started orbiting the moon at 5 p.m. (2200 GMT) Saturday.The insertion maneuvers placed the spacecraft into a near-polar, elliptical orbit with an orbital period of approximately 11.5 hours, NASA said.Over the coming weeks, the GRAIL team will execute a series of burns with each spacecraft to reduce their orbital period to just under two hours. At the start of the science phase in March 2012, the twin GRAILs will be in a near-polar, near-circular orbit with an altitude of about 55 km."NASA greets the new year with a new mission of exploration," Administrator Charles Bolden said in a statement. "The twin GRAIL spacecraft will vastly expand our knowledge of our moon and the evolution of our own planet."During GRAIL's science mission, the two probes will transmit radio signals precisely defining the distance between them. As they fly over areas of greater and lesser gravity caused by visible features such as mountains, craters and masses hidden beneath the lunar surface, the distance between the twin spacecraft will change slightly.Scientists will translate this information into a high-resolution map of the moon's gravitational field.The data will allow scientists to understand what goes on below the lunar surface and increase knowledge of how Earth and its rocky neighbors in the inner solar system developed into the diverse worlds we see today.

JERUSALEM, Jan. 12 (Xinhua) -- An Israeli company has developed a system that scans the brain and provides a three dimensional image of the nerve cell connectivity to treat brain diseases like Alzheimer's or HDHD.The firm ElMindA trademarked a non-invasive system, the BNA ( Brain Network Activation), that helps doctors visualize the connectivity between nerve cells and synchronization that can even measure the severity of the patients condition from one day to another, the Israel21c news site reported on ThursdayBy creating a three-dimensional image of the brain while asking the patients to repeat an activity several times, BNA developers hope this system will become a regular way of diagnosing brain illnesses."Our vision is that every psychiatrist and neurologist in the world will routinely send every patient for BNA tests," said Dr. Eli Zangvil, ElMindA's strategic advisor for business development. "Our test would add information and aid in diagnostics in a way no other existing technology can do," he added.BNA could help doctors find out exactly at what stage of the disease patients and prescribe the exact medication for them."To do that, we must collect a lot of data," Zangvil said. "To say this person has a certain disease or condition, I have to be able to compare their pattern to a normal brain pattern of a person of the same age and gender." he said.Researchers hope to gather the amount of data they need to obtain FDA approval in the U.S. by the end of 2012, and start marketing it to hospitals by 2013.

UNITED NATIONS, Jan. 24 (Xinhua) -- China welcomes and supports all efforts and measures that would break the current deadlock of the Palestinian-Israeli negotiation and relaunch their dialogues, Chinese UN ambassador Li Baodong said here Tuesday.Li made the remarks when addressing a Security Council monthly open debate on Middle East."The Middle East peace process is currently in a stalemate. China is deeply concerned over the development," Li said."We always maintain that the parties concerned should resolve their disputes through political negotiations under the relevant UN resolutions, the principle of 'land for peace,' the Arab Peace Initiative and the Middle East Roadmap for Peace with the goal of ultimately establishing an independent Palestinian state and two states,Palestine and Israel, living side by side in peace," he said. China appreciates the efforts made recently by Jordan and Quartet of Middle East to facilitate the two parties to have direct contact, said Li, adding "We hope the relevant peace promotion efforts will help resume the Palestinian-Israeli peace negotiation sooner and achieve substantive result. China supports a greater role of the UN in resolving the Middle East issue."Calling the Israeli settlement "a major obstacle" for the resumption of Palestinian-Israel peace negotiation, Li said China is seriously concerned about the recent approval by the Israeli government of plans for expansion of new settlements."China is always against Israeli establishment of Jewish settlements in the occupied Palestinian territory including East Jerusalem. We urge Israel to cease the settlement construction immediately, be prudent in action and work actively in collaboration with the efforts of the international community to promote peace, and create conditions for the resumption Palestinian-Israeli peace negotiation," the ambassador said.China has always supported the Palestinian people in their just cause to restore the lawful rights of the nation, and maintained that establishment of an independent state is the lawful right of the Palestinian people as the basis for the implementation of the "two-state solution""China supports the establishment of an independent Palestinian state that enjoys full sovereignty, with East Jerusalem as its capital and based on the 1967 border. China supports Palestine's membership in the United Nation," Li said.The Syria-Israel track and the Lebanon-Israel track are important component of the Middle East peace process, and play an indispensable role in the overall settlement of the Middle East issue, Li said.China firmly supports the just cause of Syria and Lebanon to maintain sovereignty and territorial integrity, and recover their occupied territoriesChina supports the strategic choice made by Arab states in their pursuit of a comprehensive and lasting peace in the region, Li added.He also called on relevant parties to keep constrained, avoid the escalation of tension in Gaza, effectively implement relevant UN resolutions and fully lift the Gaza blockade.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze."The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.Side effects associated with Erwinaze treatment include serious allergic reactions, inflammation of the pancreas, high blood levels of liver enzymes, blood clotting, bleeding, nausea, vomiting and high blood sugar.

来源：资阳报